$ALTO
Alto Ingredients, Inc. Stock $alto

$alto Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023037706 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$317.3M	$313.9M	$308.1M
YoY Change	-12.39%	1.87%	40.89%
Cost Of Revenue	$300.1M	$317.1M	$303.3M
YoY Change	-15.06%	4.52%	48.05%
Gross Profit	$17.18M	-$3.164M	$4.773M
YoY Change	94.27%	-166.29%	-65.41%
Gross Profit Margin	5.41%	-1.01%	1.55%
Selling, General & Admin	$7.911M	$7.882M	$7.629M
YoY Change	-12.06%	3.32%	8.99%
% of Gross Profit	46.05%		159.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.680M	$6.055M	$6.134M
YoY Change	-15.58%	-1.29%	4.68%
% of Gross Profit	33.06%		128.51%
Operating Expenses	$7.911M	$7.882M	$7.629M
YoY Change	-12.06%	3.32%	8.99%
Operating Profit	$9.270M	-$11.62M	-$2.856M
YoY Change	-6198.68%	306.86%	-142.0%
Interest Expense	-$1.734M	-$1.565M	-$200.0K
YoY Change	443.57%	682.5%	-89.47%
% of Operating Profit	-18.71%
Other Income/Expense, Net	$59.00K	$19.00K	$454.0K
YoY Change	-189.39%	-95.81%	-49.56%
Pretax Income	$7.595M	-$13.17M	-$2.602M
YoY Change	-65.66%	406.0%	-155.36%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	$7.595M	-$13.17M	-$2.602M
YoY Change	-65.66%	406.0%	-155.62%
Net Earnings / Revenue	2.39%	-4.19%	-0.84%
Basic Earnings Per Share	$0.10	-$0.18	-$0.04
Diluted Earnings Per Share	$0.10	-$0.18	-$36.45K
COMMON SHARES
Basic Shares Outstanding	76.11M shares	75.14M shares	71.39K shares
Diluted Shares Outstanding	74.10K shares	73.82K shares	71.39K shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$22.74M	$21.17M	$36.18M
YoY Change	-60.37%	-41.49%	-17.95%
Cash & Equivalents	$22.74M	$21.17M	$36.18M
Short-Term Investments
Other Short-Term Assets	$5.919M	$5.217M	$53.54M
YoY Change	-46.58%	-90.26%	-37.52%
Inventory	$71.12M	$67.15M	$58.49M
Prepaid Expenses
Receivables	$63.37M	$66.54M	$93.00M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$179.5M	$171.6M	$241.2M
YoY Change	-34.36%	-28.86%	-0.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$246.7M	$244.2M	$236.1M
YoY Change	10.65%	3.42%	-0.76%
Goodwill	$5.970M	$5.970M
YoY Change	1.05%
Intangibles	$8.792M	$8.940M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.993M	$6.172M	$5.142M
YoY Change	7.17%	20.03%	-4.78%
Total Long-Term Assets	$291.9M	$288.3M	$256.7M
YoY Change	13.21%	12.33%	-1.1%
TOTAL ASSETS
Total Short-Term Assets	$179.5M	$171.6M	$241.2M
Total Long-Term Assets	$291.9M	$288.3M	$256.7M
Total Assets	$471.4M	$459.9M	$497.9M
YoY Change	-11.28%	-7.63%	-0.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$25.93M	$24.41M	$21.75M
YoY Change	20.74%	12.21%	-6.25%
Accrued Expenses	$15.33M	$17.33M	$23.78M
YoY Change	-28.39%	-27.09%	46.77%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$58.69M	$53.85M	$80.18M
YoY Change	-38.31%	-32.84%	-28.92%
LONG-TERM LIABILITIES
Long-Term Debt	$82.08M	$83.74M	$53.68M
YoY Change	56.29%	55.99%	-16.64%
Other Long-Term Liabilities	$8.791M	$8.966M	$21.04M
YoY Change	-14.55%	-57.39%	-5.65%
Total Long-Term Liabilities	$90.87M	$92.71M	$74.72M
YoY Change	44.69%	24.07%	-13.82%
TOTAL LIABILITIES
Total Short-Term Liabilities	$58.69M	$53.85M	$80.18M
Total Long-Term Liabilities	$90.87M	$92.71M	$74.72M
Total Liabilities	$170.6M	$166.2M	$154.9M
YoY Change	1.72%	7.31%	-22.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$740.8M	-$748.1M
YoY Change	10.1%
Common Stock	$76.00K	$76.00K	$5.000M
YoY Change	2.7%	-98.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$300.8M	$293.7M	$343.0M
YoY Change
Total Liabilities & Shareholders Equity	$471.4M	$459.9M	$497.9M
YoY Change	-11.28%	-7.63%	-0.64%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$7.595M	-$13.17M	-$2.602M
YoY Change	-65.66%	406.0%	-155.62%
Depreciation, Depletion And Amortization	$5.680M	$6.055M	$6.134M
YoY Change	-15.58%	-1.29%	4.68%
Cash From Operating Activities	$10.44M	-$23.35M	$11.06M
YoY Change	8.43%	-311.02%	-371.18%
INVESTING ACTIVITIES
Capital Expenditures	$8.366M	$9.602M	-$2.334M
YoY Change	-212.63%	-511.4%	-47.07%
Acquisitions			$14.66M
YoY Change
Other Investing Activities	$0.00	-$3.500M	-$14.66M
YoY Change		-76.12%
Cash From Investing Activities	-$8.366M	-$13.10M	-$16.99M
YoY Change	12.63%	-22.88%	285.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.423M	$13.36M	3.783M
YoY Change	-127.27%	253.16%	-23.88%
NET CHANGE
Cash From Operating Activities	10.44M	-$23.35M	11.06M
Cash From Investing Activities	-8.366M	-$13.10M	-16.99M
Cash From Financing Activities	-3.423M	$13.36M	3.783M
Net Change In Cash	-1.346M	-$23.09M	-2.142M
YoY Change	-109.12%	977.92%	-39.15%
FREE CASH FLOW
Cash From Operating Activities	$10.44M	-$23.35M	$11.06M
Capital Expenditures	$8.366M	$9.602M	-$2.334M
Free Cash Flow	$2.077M	-$32.95M	$13.40M
YoY Change	-87.82%	-345.92%	3960.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	28115000	usd
CY2022Q4	alto	Current Portion Operating Leases CurrentPortionOperatingLeases	3849000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-24172000	usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-21467
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-2170618
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1300 South Second Street
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Pekin
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	61554
CY2023Q1	dei	City Area Code CityAreaCode	(916)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	403-2123
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	ALTO
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	76105690	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21173000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	5263000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	66000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	66537000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	67147000	usd
CY2023Q1	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	6267000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	5217000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	171604000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	244172000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	23046000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	18937000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8940000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	5970000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6172000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	44128000	usd
CY2023Q1	us-gaap	Assets Assets	459904000	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	24406000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17334000	usd
CY2023Q1	alto	Current Portion Operating Leases CurrentPortionOperatingLeases	3856000	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2100000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6150000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	53846000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	83739000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	19678000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8966000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	166229000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	18075000	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	76187000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76187000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	76000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1039897000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1822000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-748121000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	293675000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	459904000	usd
CY2023Q1	us-gaap	Revenues Revenues	313891000	usd
CY2022Q1	us-gaap	Revenues Revenues	308118000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	317055000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	303345000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-3164000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	4773000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7882000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7629000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	574000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11620000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2856000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1565000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-200000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	454000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	-13166000	usd
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	-2602000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13166000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2602000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	312000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	312000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13478000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2914000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73815	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71390	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73815	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71390	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13166000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2602000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	6055000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	6134000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1777000	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	5316000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	752000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	673000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-574000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	235000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6000	usd
CY2023Q1	alto	Interest Expense Added To Senior Notes InterestExpenseAddedToSeniorNotes	198000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-39000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	31000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2157000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11775000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	519000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2773000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4027000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-14119000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1226000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1257000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-9726000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23347000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11064000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9602000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2334000	usd
CY2023Q1	alto	Deferred Purchase Price Payments For Eagle Alcohol DeferredPurchasePricePaymentsForEagleAlcohol	3500000	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	14655000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13102000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16989000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	15354000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	3314000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1682000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	781000	usd
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	312000	usd
CY2022Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	312000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13360000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3783000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-23089000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2142000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49525000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62125000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26436000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59983000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21173000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36184000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	5263000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	23799000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	26436000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	59983000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1886000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	195000	usd
CY2023Q1	alto	Capitalized Interest CapitalizedInterest	839000	usd
CY2022Q1	alto	Capitalized Interest CapitalizedInterest	45000	usd
CY2023Q1	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	350000000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	47736000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	5321000	usd
CY2023Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	1600000	usd
CY2023Q1	us-gaap	Accounts Receivable Sale AccountsReceivableSale	53655000000	usd
CY2022	us-gaap	Accounts Receivable Sale AccountsReceivableSale	55667000000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	66000000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	105000000	usd
CY2023Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	39000000	usd
CY2023Q1	alto	Bad Debt Expense BadDebtExpense	31000000	usd
CY2022Q1	alto	Bad Debt Expense BadDebtExpense	31000000	usd
CY2022Q3	alto	Repurchase Of Common Stock RepurchaseOfCommonStock	50000000	usd
CY2022Q3	alto	Excess Amount Of Initial Purchase ExcessAmountOfInitialPurchase	10000000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000	usd
CY2023Q1	alto	Purchase Authorization Additional Lender Value PurchaseAuthorizationAdditionalLenderValue	5000000	usd
CY2023Q1	alto	Purchase Additional Amount PurchaseAdditionalAmount	10000000	usd
CY2023Q1	alto	Repurchased Aggregate Shares RepurchasedAggregateShares	860000000	shares
CY2023Q1	alto	Repurchased An Aggregate Shares In Cash RepurchasedAnAggregateSharesInCash	1682000000	usd
CY2023Q1	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	3007000000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	6396000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	16055000	usd
CY2023Q1	alto	Incomeloss Before Benefit For Income Taxes IncomelossBeforeBenefitForIncomeTaxes	-13166000	usd
CY2022Q1	alto	Incomeloss Before Benefit For Income Taxes IncomelossBeforeBenefitForIncomeTaxes	-2602000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6055000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6134000	usd
CY2023Q1	alto	Interest Expenses InterestExpenses	1565000	usd
CY2022Q1	alto	Interest Expenses InterestExpenses	200000	usd
CY2023Q1	us-gaap	Assets Assets	459904000	usd
CY2022Q4	us-gaap	Assets Assets	478321000	usd
CY2023Q1	us-gaap	Inventory Parts And Components Net Of Reserves InventoryPartsAndComponentsNetOfReserves	0	usd
CY2022Q4	us-gaap	Inventory Parts And Components Net Of Reserves InventoryPartsAndComponentsNetOfReserves	4612000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	44309000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	11197000	usd
CY2023Q1	us-gaap	Other Inventory OtherInventory	1462000	usd
CY2022Q4	us-gaap	Other Inventory OtherInventory	1299000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	67147000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	66628000	usd
CY2023Q1	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	1777000	usd
CY2022Q1	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	5316000	usd
CY2023Q1	alto	Type Of Instrument Cash Collateral Balance TypeOfInstrumentCashCollateralBalance	Cash collateral balance
CY2023Q1	alto	Assets Balance Sheet Location Restrictedcashs AssetsBalanceSheetLocationRestrictedcashs	Restricted cash
CY2023Q1	alto	Assets Fair Value Restrictedcash AssetsFairValueRestrictedcash	5263000	usd
CY2023Q1	alto	Type Of Instrument Commoditys Contracts1 TypeOfInstrumentCommoditysContracts1	Commodity contracts
CY2023Q1	alto	Assets Balance Sheet Location Derivatives Assets AssetsBalanceSheetLocationDerivativesAssets	Derivative instruments
CY2023Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	6267000	usd
CY2023Q1	alto	Liabilities Balance Sheet Location Commodity Contracts LiabilitiesBalanceSheetLocationCommodityContracts	Derivative instruments
CY2023Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	2100000	usd
CY2022	alto	Type Of Instrument Cash Collateral Balance TypeOfInstrumentCashCollateralBalance	Cash collateral balance
CY2022	alto	Assets Balance Sheet Location Restrictedcashs AssetsBalanceSheetLocationRestrictedcashs	Restricted cash
CY2022Q4	alto	Assets Fair Value Restrictedcash AssetsFairValueRestrictedcash	13069000	usd
CY2022	alto	Type Of Instrument Commoditys Contracts1 TypeOfInstrumentCommoditysContracts1	Commodity contracts
CY2022	alto	Assets Balance Sheet Location Derivatives Assets AssetsBalanceSheetLocationDerivativesAssets	Derivative instruments
CY2022Q4	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	4973000	usd
CY2022	alto	Liabilities Balance Sheet Location Commodity Contracts LiabilitiesBalanceSheetLocationCommodityContracts	Derivative instruments
CY2022Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	6732000	usd
CY2023Q1	us-gaap	Notes Payable NotesPayable	93430000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	78076000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4497000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4686000	usd
CY2023Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	5194000	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	5034000	usd
CY2023Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	83739000	usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	68356000	usd
CY2023Q1	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	41600000	usd
CY2023Q1	us-gaap	Significant Supply Commitment Remaining Minimum Amount Committed SignificantSupplyCommitmentRemainingMinimumAmountCommitted	13652000	usd
CY2023Q1	alto	Indexedprice Purchase Contracts IndexedpricePurchaseContracts	128000	pure
CY2023Q1	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	21730000	usd
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	21661000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13166000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	312000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13478000	usd
CY2023Q1	alto	Net Loss Available To Common Stockholders Shares Denominator NetLossAvailableToCommonStockholdersSharesDenominator	73815000	shares
CY2023Q1	alto	Net Loss Available To Common Stockholders Per Share Amount NetLossAvailableToCommonStockholdersPerShareAmount	-0.18
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2602000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	312000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2914000	usd
CY2022Q1	alto	Net Loss Available To Common Stockholders Shares Denominator NetLossAvailableToCommonStockholdersSharesDenominator	71390000	shares
CY2022Q1	alto	Net Loss Available To Common Stockholders Per Share Amount NetLossAvailableToCommonStockholdersPerShareAmount	-0.04
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	964000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1339000	shares
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Alto Ingredients, Inc.
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic		usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic		usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2022Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2022Q1	alto	Interest Expense Added To Senior Notes InterestExpenseAddedToSeniorNotes		usd
CY2022Q1	alto	Deferred Purchase Price Payments For Eagle Alcohol DeferredPurchasePricePaymentsForEagleAlcohol		usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt		usd
CY2023Q1	alto	Liabilities Balance Sheet Location LiabilitiesBalanceSheetLocation
CY2023Q1	us-gaap	Fair Value Hedge Liabilities At Fair Value FairValueHedgeLiabilitiesAtFairValue		usd
CY2022	alto	Liabilities Balance Sheet Location LiabilitiesBalanceSheetLocation
CY2022Q4	us-gaap	Fair Value Hedge Liabilities At Fair Value FairValueHedgeLiabilitiesAtFairValue		usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2023Q1	alto	Less Preferred Stock Dividends Shares Denominator LessPreferredStockDividendsSharesDenominator		shares
CY2023Q1	alto	Less Preferred Stock Dividends Per Share Amount LessPreferredStockDividendsPerShareAmount
CY2022Q1	alto	Less Preferred Stock Dividends Shares Denominator LessPreferredStockDividendsSharesDenominator		shares
CY2022Q1	alto	Less Preferred Stock Dividends Per Share Amount LessPreferredStockDividendsPerShareAmount
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000778164

Files In Submission

Name	View Source	Status
alto-20230331_def.xml	Edgar Link	unprocessable
alto-20230331_cal.xml	Edgar Link	unprocessable
0001213900-23-037706-index-headers.html	Edgar Link	pending
0001213900-23-037706-index.html	Edgar Link	pending
0001213900-23-037706.txt	Edgar Link	pending
0001213900-23-037706-xbrl.zip	Edgar Link	pending
alto-20230331.xsd	Edgar Link	pending
f10q0323ex31-1_altoingred.htm	Edgar Link	pending
f10q0323ex31-2_altoingred.htm	Edgar Link	pending
f10q0323ex32-1_altoingred.htm	Edgar Link	pending
f10q0323_altoingred.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
alto-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
alto-20230331_lab.xml	Edgar Link	unprocessable
f10q0323_altoingred_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALTO
Alto Ingredients, Inc. Stock $alto

2023 Q2 Form 10-Q Financial Statement

#000121390023037706 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALTO Alto Ingredients, Inc. Stock $alto

2023 Q2 Form 10-Q Financial Statement

#000121390023037706 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALTO
Alto Ingredients, Inc. Stock $alto